Both in Pharmaceuticals
Ardelyx vs Kura Oncology
Over the past year ARDX returned −39.5% and KURA returned −10.1%; their daily moves had a correlation of 0.20.
ARDX −39.5% KURA −10.1%Growth of $1, one year, split-adjusted
| Metric | ARDX | KURA |
|---|---|---|
| Price | $3.11 | $9.26 |
| Market cap | $801.7M | $823.3M |
| Today | −5.05% | −4.59% |
| 1 month | −8.1% | −21.0% |
| 6 months | −51.9% | −4.4% |
| Year to date | −46.7% | −10.9% |
| 1 year | −39.5% | −10.1% |
| Revenue growth (YoY) | +23.8% | +36.5% |
| Gross margin | 95.2% | 98.8% |
| Net margin | −13.8% | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.8× | 10.7× |
| Net cash | $30.0M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 49.5% | 54.9% |
| Short % of float | 11.4% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).